Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-12-11

FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for BENICAR (olmesartan medoxomil) by Cosette Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BENICAR (OLMESARTAN MEDOXOMIL)

Snippet

SUPPL AP for BENICAR (OLMESARTAN MEDOXOMIL)